61096-1022 NDC - HAIR AND NAIL TONIC (AVENA, DNA, ELAEIS, GLANDULA SUPRARENALIS SUIS, HAMAMELIS, HEPAR SUIS, KALI SULPH, NAT MUR, NICOTINAMIDUM, PHOSPHORICUM AC, PITUITARUM POSTERIUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, THUJA OCC, THYROIDINUM, URTICA UR.)

Drug Information

  • Product NDC: 61096-1022
  • Proprietary Name: Hair and Nail Tonic
  • Non Proprietary Name: Avena, DNA, Elaeis, Glandula suprarenalis suis, Hamamelis, Hepar suis, Kali sulph, Nat mur, Nicotinamidum, Phosphoricum ac, Pituitarum posterium, Riboflavinum, Thiaminum hydrochloricum, Thuja occ, Thyroidinum, Urtica ur.
  • Active Ingredient(s): 4 [hp_X]/41mL AVENA SATIVA FLOWERING TOP; 15 [hp_X]/41mL ELAEIS GUINEENSIS FRUIT; 4 [hp_X]/41mL HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; 12 [hp_X]/41mL HERRING SPERM DNA; 6 [hp_X]/41mL NIACINAMIDE; 4 [hp_X]/41mL PHOSPHORIC ACID; 6 [hp_X]/41mL PORK LIVER; 30 [hp_C]/41mL POTASSIUM SULFATE; 8 [hp_X]/41mL RIBOFLAVIN; 200 [hp_C]/41mL SODIUM CHLORIDE; 30 [hp_C]/41mL SUS SCROFA ADRENAL GLAND; 10 [hp_X]/41mL SUS SCROFA PITUITARY GLAND; 6 [hp_X]/41mL THIAMINE HYDROCHLORIDE; 200 [hp_C]/41mL THUJA OCCIDENTALIS LEAFY TWIG; 30 [hp_C]/41mL THYROID, UNSPECIFIED; 4 [hp_X]/41mL URTICA URENS WHOLE
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Eight and Company L.L.C
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:3/8/2019
End Marketing Date:4/28/2028

Package Information

No. Package Code Package Description Billing Unit
161096-1022-11 BOTTLE, SPRAY in 1 CARTON (61096-1022-1) / 41 mL in 1 BOTTLE, SPRAY

NDC Record

Field Name Field Value Definition
PRODUCT NDC61096-1022The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEHair and Nail TonicThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAvena, DNA, Elaeis, Glandula suprarenalis suis, Hamamelis, Hepar suis, Kali sulph, Nat mur, Nicotinamidum, Phosphoricum ac, Pituitarum posterium, Riboflavinum, Thiaminum hydrochloricum, Thuja occ, Thyroidinum, Urtica ur.The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/8/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE4/28/2028This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEight and Company L.L.CName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAVENA SATIVA FLOWERING TOP; ELAEIS GUINEENSIS FRUIT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HERRING SPERM DNA; NIACINAMIDE; PHOSPHORIC ACID; PORK LIVER; POTASSIUM SULFATE; RIBOFLAVIN; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THIAMINE HYDROCHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; URTICA URENS WHOLEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH4; 15; 4; 12; 6; 4; 6; 30; 8; 200; 30; 10; 6; 200; 30; 4 
ACTIVE INGRED UNIT[hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL 
PHARM CLASSESIncreased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code